Abstract
During a two-year period, 12 patients with indication for inferior vena cava interruption underwent vena cava occlusion with the transvenous Hunter-Sessions balloon. The device permitted simultaneous anticoagulation (when not contraindicated), was tolerated by sick patients, did not cause mortality or significant morbidity, and prevented pulmonary emboli.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
